Endurance
Engineered for maximum wear time.
Confidence
Never lose a device.
Freedom
Skin Grip moves with you, never against you.
SHOP BESTSELLERS
Skin Grip Original - Dexcom G6 Patches
Choose your option
Skin Grip MAX Dexcom G6 Patches - 10 Pack
Choose your option
Skin Grip Original - Medtronic Guardian/Enlite Adhesive Patches
Choose your option
Skin Grip Original - Freestyle Libre 2+ & Lingo Adhesive Patches
Choose your option
Skin Grip MAX Dexcom G7 & Stelo Patches - 10 Pack
Choose your option
Skin Grip Original - Dexcom G7 & Stelo Adhesive Patches (With Cutout)
Choose your option
Skin Grip Original - Omnipod Adhesive Patches
Choose your option
Skin Grip Original - Dexcom G7 & Stelo Adhesive Patches
Choose your option
Skin Grip - Tandem Mobi Pocket Patch
Choose your option
Sensors Saved
Trusted By
Say Goodbye To
Sensor Failure Mid-Routine
Adhesion built to last through motion, sweat, and time.
Manufacturer Replacements on Repeat
Designed for reliability — not replacements.
Waiting on New Sensors to Arrive
Every patch extends your wear. Every day counts.
Losing a Reading When Life Gets Close
Holds steady through hugs, heat, and high impact.
Returning to Fingerpricks and Frustration
Performance that stays put. Confidence that stays on.
→ Built to grip. Made to stay.
DIABETES MANAGEMENT
Your go-to hub for tips, tricks, and real talk on living boldly with diabetes
AI Is Quietly Changing Diabetes Tech – Here’s What That Actually Means
AI is everywhere. Not without some controversy, it shows up in headlines, product launches, and in just about every industry. In diabetes tech, the shift to AI has been subtle in nature yet quietly impactful in improving day-to-day life. This isn’t about fully hands-off systems just yet. It’s about something more immediate: technology that’s starting to take a step ahead, so you don’t have to think through every single decision in real time. It’s Already Happening (Even If It Doesn’t Feel Like It) If you use an automated insulin delivery system, you’ve probably noticed that things feel a little smoother than they used to. That’s not by accident. Modern systems aren’t just responding to your current glucose reading. They’re watching trends, adjusting insulin in the background, and making small changes throughout the day and night. It might not be labeled as AI in big bold letters, but the underlying algorithms are getting more advanced with each update. The result is subtle, but meaningful. There’s often less need to chase highs or react quickly to drops because the system is already working behind the scenes. Prediction Is Getting Better—and Faster One of the biggest shifts happening right now is how early systems can respond. Instead of waiting for a high or low to happen, newer algorithms are getting better at predicting where your glucose is headed and adjusting before you feel the impact. This is where AI plays a bigger role. These systems are processing patterns that would be difficult to track manually, especially over days and weeks of data. Over time, they start to recognize how your body typically responds and use that information to act sooner. What this looks like day to day is fewer surprises. You may still see fluctuations, but they’re often less abrupt and easier to manage. The Pressure to Be “Perfect” Is Starting to Ease For a long time, diabetes tech has relied heavily on precise inputs. Exact carb counts, carefully timed boluses, and constant adjustments have been part of the routine. That expectation is starting to shift. Newer systems are getting better at correcting for missed or imperfect inputs. If a meal estimate is off or a bolus is delayed, the system can often step in and help smooth things out. Some platforms are even moving toward simplified meal inputs instead of requiring exact numbers. It doesn’t remove the need for involvement, but it does take some of the pressure off getting everything exactly right. Apps Are Starting to Act More Like a Co-Pilot AI isn’t just showing up in pumps. It’s also becoming more visible in apps and software that work alongside CGMs. Instead of simply displaying data, these tools are starting to interpret it. They can highlight patterns, flag trends, and in some cases suggest next steps based on what they’re seeing. That means less time staring at graphs and trying to figure out what changed, and more clarity around what’s actually happening. It’s a shift from raw data to something more useful and actionable. Systems Are Beginning to Learn You This might be the most meaningful change of all. Earlier systems depended on settings that you had to dial in and adjust over time. Basal rates, ratios, and correction factors were often static unless you changed them. Now, systems are starting to adapt more dynamically. They learn from your patterns, adjust to your routines, and gradually align more closely with how your body actually behaves. Instead of forcing your day to fit the system, the system is starting to fit your day. That doesn’t mean it’s perfect, but it does mean less constant tweaking. What AI Doesn’t Solve Even with all this progress, there are still limits. Diabetes is complex, and not everything is predictable. Meals, movement, stress, and hormones can all affect glucose in ways that are hard to anticipate. Technology can support you, but it doesn’t replace awareness entirely. There are still moments where you need to step in and make decisions. The Bigger Shift: Less Mental Load The real impact of AI in diabetes tech isn’t about the technology itself. It’s about how it changes the experience of living with diabetes. There are fewer urgent decisions, fewer interruptions, and a growing sense that your system is helping carry some of the weight. You’re still involved, but you’re not doing everything on your own. That shift adds up over time. Final Thoughts AI in diabetes tech isn’t something that’s coming in the future. It’s already here, just in a quieter, more gradual way. It shows up in how your system predicts trends, adjusts insulin, and learns from your data. Each update may feel small, but together they’re moving things in a clear direction. Less effort. More support. More space to focus on the rest of your life.
Read more
Dual-Hormone Systems Are Coming: Insulin + Glucagon Tech to Watch
Most diabetes technology today is built around one main job: delivering insulin. And or many people, automated insulin delivery systems have already made life a lot easier. But there’s still one missing piece. Your body doesn’t just use insulin. It also uses glucagon, a hormone that raises blood sugar when it drops too low. And now, companies are actively working on systems that use both. These are called dual-hormone systems, and they could represent one of the biggest shifts in diabetes tech in years. What Is a Dual-Hormone System? A dual-hormone system is simple in concept: it's designed to deliver both insulin to bring glucose down and glucagon to raise it back up. Instead of relying only on insulin and treating lows with glucose, these systems aim to automatically balance both sides, mimicking how a pancreas works. By delivering small doses of glucagon and insulin, these dual-hormone systems will reduce the need for constant intervention and hyper vigilance. What’s New in This Space Dual-hormone systems have been studied for years, but a few key shifts are moving things forward. More Stable Glucagon One of the biggest barriers has been glucagon stability. Traditional glucagon breaks down quickly once mixed, making it difficult to use in a pump. Newer formulations, like dasiglucagon, are much more stable and designed for continuous use. This has opened the door for real device development. More Advanced Algorithms Modern systems are getting better at coordinating insulin and glucagon delivery. Recent research shows: Improved time in range Fewer hypoglycemic events Better overall glucose stability These systems are learning how to balance both hormones in real time, which is a major step forward. Who’s Actually Building These Systems? This isn’t just theoretical. There are real companies working on this right now. Beta Bionics Beta Bionics is leading the charge with its iLet Bionic Pancreas. The current iLet system is insulin-only The platform is designed to support a dual-hormone version Ongoing trials are testing systems that use insulin + dasiglucagon Beta Bionics has partnered with companies like Xeris to support stable glucagon delivery, which is a key piece of making this work in real life. This is the closest system to becoming widely available in the future. Inreda Diabetic Inreda, based in Europe, has already developed a dual-hormone artificial pancreas system that delivers both insulin and glucagon. It has been used in limited real-world settings It mimics natural pancreatic function more closely than insulin-only systems While not widely available yet, it shows that dual-hormone systems can work outside of research environments. What’s Still Challenging There are still hurdles to overcome: Device complexity (two hormones instead of one) Cost and accessibility Regulatory approval timelines Real-world usability These systems are promising, but not ready for widespread use just yet. What to Expect in the Next 3–5 Years Here’s a realistic look at what’s ahead: Next 1–2 Years Continued clinical trials of dual-hormone systems More data presented at conferences like ATTD and ADA Refinement of glucagon formulations 2–3 Years Expanded real-world testing More companies entering the space Early regulatory conversations 3–5 Years Potential first broader commercial launches More user-friendly system designs Integration with existing CGMs and pump ecosystems Timelines can shift, but the momentum is clearly building. Final Thoughts We’re still early, but this space is moving faster than it has in years. With companies like Beta Bionics pushing forward and real-world systems already being tested, dual-hormone technology is becoming more tangible. It won’t replace everything overnight, but it could significantly decrease the number of decisions required every day, reducing the mental load of living with diabetes.
Read more
Are We Getting Closer to a Fully “Hands-Off” System?
If you use a CGM or insulin pump, you’ve probably had this thought at some point: “Will there ever be a system that just…handles it for me?” No carb counting, no constant adjustments, no mental math. Just something that works in the background so you can live your life. We’re not fully there yet, but we’re closer than ever. Recent updates from diabetes technology conferences like ATTD show that the industry is steadily moving toward more automated, lower-effort systems. Here’s what that actually means, and how close we are to a true “hands-off” experience. First, Where We Are Today (Quick Reality Check) Current systems like Control-IQ, Omnipod 5, Medtronic SmartGuard, twiist, and iLet already: Adjust insulin automatically Help prevent highs and lows Reduce overnight variability But they still rely on you for: Meal boluses Carb counting (or at least estimating) Managing unexpected situations So while they’re powerful, they’re not fully hands-off. What’s Actually Changing: The Tech Moving Us Forward Here’s where things get interesting and much more specific. 1. Systems That Can Detect Meals (Without You Saying Anything) One of the biggest barriers to full automation has always been meals. At ATTD, multiple research groups and companies presented progress toward systems that can: Detect when you’ve eaten Respond automatically with insulin Correct for missed or underestimated meals Some experimental systems are using AI and pattern recognition to identify meal-related glucose rises in real time without requiring manual carb input. What this means in real life: You forget to bolus…and your system steps in anyway. This alone is one of the biggest steps toward reducing daily decision-fatigue. 2. AI That Predicts What’s About to Happen We’ve had “smart” systems for a while, but what’s new is how predictive they’re becoming. Recent developments include: Algorithms that forecast glucose trends 30+ minutes ahead Systems that adjust insulin before a high or low fully develops AI models that process large amounts of CGM data to recognize patterns faster This is a shift from: reacting to glucose changes to preventing them before they happen 3. Continuous Ketone Monitoring Is Entering the Chat One of the most talked-about developments from ATTD: continuous ketone monitoring (CKM). Companies like Abbott are working on sensors that track both glucose and ketones simultaneously. Why that matters: Ketones provide context that glucose alone can’t They can signal risk earlier (like during illness or insulin disruption) They give automated systems more information to make better decisions This means that future systems won’t just know your number - they’ll understand your metabolic state, which will make automation safer and smarter. 4. Less Carb Counting, More “Good Enough” Input Another clear shift: systems are moving away from requiring precision. Instead of exact carb counts, we’re seeing: Simplified meal announcements (small/medium/large) Systems that correct for estimation errors Algorithms that learn your patterns over time This is especially visible in systems such as iLet, which already reduces the need for detailed setup. 5. Automation That Works for More People (Not Just One Type of User) At ATTD, companies such as Tandem shared data showing automated systems working across: Different insulin needs Different daily routines Broader populations, including type 2 diabetes This matters because: More variability = stronger algorithms Systems are being built to adapt, not assume 6. The Rise of “Co-Pilot” Systems Not every innovation is about full automation. There’s also a growing category of tools that act like a diabetes co-pilot: Apps that analyze your CGM data and suggest actions AI tools that flag patterns you might miss Systems that guide decisions without fully taking over These tools don’t replace you, but they reduce the mental load significantly. So… Are We Close to Fully Hands-Off? Closer than we’ve ever been, but not quite there yet. What’s still challenging: Insulin timing isn’t instant Meals vary too much to perfectly predict every time Activity, stress, and hormones still introduce variability Sensors and delivery systems aren’t perfect But here’s what has changed: We’re no longer just improving devices. We’re building systems that: Learn from you Predict what’s coming Fill in the gaps when you don’t act The Bigger Shift: From Management to Support The most important takeaway isn’t “full automation is coming.” It’s that diabetes tech is moving from something you manage to something that supports you in the background though: Fewer interruptions Less decision fatigue More trust in your system More space to focus on your life Final Thoughts A fully hands-off diabetes system isn’t here yet, but for the first time, we’re seeing real, concrete steps toward it through meal detection, predictive AI, multi-analyte sensors and adaptive algorithms. And while we’re still in the in-between, each update is doing something meaningful: Giving you a little more breathing room so you can live fearlessly.
Read more
